Loading clinical trials...

The Senstivity and Specificity of Using Salivary miRNAs in Detection of Malignant Transformation of Oral Lesions. | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT04913545

The Senstivity and Specificity of Using Salivary miRNAs in Detection of Malignant Transformation of Oral Lesions.

Due to cancer is a leading cause of death world wide , we will coduct the study to evaluate the diagnostic accuracy of using salivary miRNAs (412,512) from the salivary extracellular vesicles (index t...

Lead sponsor: Cairo University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

UNKNOWNPhase 2

Immune Checkpoint Inhibitor In High Risk Oral Premalignant Lesions

NCT04504552 · Oral Premalignant Lesions

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 9, 2021Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment18

Start dateJun 2019

Last updatedJun 9, 2021

Condition

Oral Premalignant Lesions

Locations shown

Dentistry

Cairo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 9, 2021Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions